{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T18:09:25Z","timestamp":1771265365885,"version":"3.50.1"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Central nervous system involvement in vasculitis disorders, either primary or secondary, is a heterogeneous and challenging area in rheumatology clinical in terms of both diagnostics and therapeutics. Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) is a rare, difficult-to-diagnose, and ill-defined clinical entity caused by mutations at the TREX1 gene without effective treatment options. We hereby present a 50-year-old male patient with non-alcoholic fatty liver disease, hypertension, bilateral type III macular telangiectasia, and stage II chronic kidney disease with mild proteinuria presenting to the rheumatology clinic with various neurological symptoms accompanied by multiple contrast-enhancing cerebral lesions on magnetic resonance imaging. Even though RVCL-S is not an inflammatory vasculopathy, our patient has partially responded to high-dose corticosteroid and cyclophosphamide in terms of clinical status and radiological evaluation. This case report not only highlights the importance of consideration of RVCL-S in the differential diagnosis of central nervous system vasculitis-like disorders but also emphasises the potential use of certain immunosuppressive medications in the therapeutic perspective.<\/jats:p>","DOI":"10.1093\/mrcr\/rxag007","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T12:41:10Z","timestamp":1769776870000},"source":"Crossref","is-referenced-by-count":0,"title":["Is it a secondary cause of vasculitis or a mimic? A case of retinal vasculopathy with cerebral leukoencephalopathy"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0190-2746","authenticated-orcid":false,"given":"Sidar","family":"\u00c7\u00f6p\u00fcr","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Koc University School of Medicine , Istanbul ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunus Emre","family":"Senturk","sequence":"additional","affiliation":[{"name":"Department of Radiology, Koc University School of Medicine , Istanbul ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunus Baran","family":"Kok","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ac\u0131badem University School of Medicine , Istanbul ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reyhan","family":"Kucukkaya","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Istanbul University School of Medicine , Istanbul ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nil\u00fcfer Alpay","family":"Kan\u0131tez","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Koc University School of Medicine , Istanbul ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"2026021612123104700_ref1","first-page":"100046","article-title":"Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S): an update on basic science and clinical perspectives","volume":"3","author":"Wilms","year":"2022","journal-title":"Cereb Circ Cogn Behav"},{"key":"2026021612123104700_ref2","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/ng2082","article-title":"C-terminal truncations in human 3\u2032-5\u2032 DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy","volume":"39","author":"Richards","year":"2007","journal-title":"Nat Genet"},{"key":"2026021612123104700_ref3","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/brain\/aww217","article-title":"Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations","volume":"139","author":"Stam","year":"2016","journal-title":"Brain"},{"key":"2026021612123104700_ref4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2008.06.032","article-title":"Trex 1 prevents cell-intrinsic initiation of autoimmunity","volume":"134","author":"Stetson","year":"2008","journal-title":"Cell"},{"key":"2026021612123104700_ref5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ana.24583","article-title":"A 44-year-old man with eye, kidney, and brain dysfunction","volume":"79","author":"Vodopivec","year":"2016","journal-title":"Ann Neurol"},{"key":"2026021612123104700_ref6","first-page":"68","article-title":"Phenotypic variability in a Mexican mestizo family with retinal vasculopathy with cerebral leukodystrophy and TREX1 mutation p.V235Gfs*6","volume":"70","author":"Monroy-Jaramillo","year":"2018","journal-title":"Rev Investig Clin"},{"key":"2026021612123104700_ref7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/jnnp-2017-316142","article-title":"Tumefactive lesions in retinal vasculopathy with cerebral leucoencephalopathy and systemic manifestations (RVCL-S): a role for neuroinflammation?","volume":"89","author":"Hardy","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026021612123104700_ref8","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1212\/WNL.0b013e3181f4d7ac","article-title":"Evolution of a tumor-like lesion in cerebroretinal vasculopathy and TREX1 mutation","volume":"75","author":"Mateen","year":"2010","journal-title":"Neurology"},{"key":"2026021612123104700_ref9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/joim.12848","article-title":"Systemic features of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: a monogenic small vessel disease","volume":"285","author":"Pelzer","year":"2019","journal-title":"J Intern Med"},{"key":"2026021612123104700_ref10","doi-asserted-by":"crossref","first-page":"1288675","DOI":"10.3389\/fimmu.2023.1288675","article-title":"Novel heterozygous TREX1 mutation in a juvenile systemic lupus erythematosus patient with severe cutaneous involvement treated successfully with Jak-inhibitors: a case report","volume":"14","author":"Rossano","year":"2023","journal-title":"Front Immunol"},{"key":"2026021612123104700_ref11","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1161\/STROKEAHA.117.018556","article-title":"Circulating endothelial markers in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations","volume":"48","author":"Pelzer","year":"2017","journal-title":"Stroke"},{"key":"2026021612123104700_ref12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.immuni.2015.07.022","article-title":"Cytosolic nuclease TREX1 regulates Oligosaccharyltransferase activity independent of nuclease activity to suppress immune activation","volume":"43","author":"Hasan","year":"2015","journal-title":"Immunity"},{"key":"2026021612123104700_ref13","doi-asserted-by":"crossref","first-page":"e1367","DOI":"10.1002\/iid3.1367","article-title":"Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations in conjunction with systemic lupus erythematosus: missed diagnosis or misdiagnosis?","volume":"12","author":"Wang","year":"2024","journal-title":"Immun Inflamm Dis"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxag007\/66640785\/rxag007.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/10\/1\/rxag007\/66640785\/rxag007.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/10\/1\/rxag007\/66640785\/rxag007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T17:12:37Z","timestamp":1771261957000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/doi\/10.1093\/mrcr\/rxag007\/8445413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxag007","relation":{},"ISSN":["2472-5625"],"issn-type":[{"value":"2472-5625","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"rxag007"}}